Company intelligence / Profile preview

93 Biotech Equity Partners

Ownership: Private
Development stage: Other

Overview

93 Biotech Equity Partners is a specialized investment firm focused on the life sciences and biotechnology sectors. The firm typically engages in identifying and investing in high-potential biotech companies, leveraging deep industry expertise to support the development of innovative therapeutics and healthcare technologies. While it does not develop its own internal drug pipeline, it plays a critical role in the biotech ecosystem by providing capital and strategic guidance to emerging companies. The firm's portfolio often spans various therapeutic areas and modalities, reflecting a broad interest in medical innovation.

Industry: Investors

Beyond the preview

Go deeper on 93 Biotech Equity Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 93 Biotech Equity Partners.

Explore the full profile